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Cell polarity in one-cell C. elegans embryos guides
asymmetric cell division and cell-fate specification.
Shortly after fertilization, embryos establish two
antagonistic cortical domains of PAR proteins.
Here, we find that the conserved polarity factor
PAR-5 regulates PAR domain size in a dose-
dependent manner. Using quantitative imaging and
controlled genetic manipulation, we find that PAR-5
protein levels reflect the cumulative output of three
mRNA isoforms with different translational effi-
ciencies mediated by their 30 UTRs. 30 UTR selection
is regulated, influencing PAR-5 protein abundance.
Alternative splicing underlies the selection of par-5
30 UTR isoforms. 30 UTR splicing is enhanced by the
SR protein kinase SPK-1, and accordingly, SPK-1 is
required for wild-type PAR-5 levels and PAR domain
size. Precise regulation of par-5 isoform selection
is essential for polarization when the posterior PAR
network is compromised. Together, strict control of
PAR-5 protein levels and feedback from polarity to
par-5 30 UTR selection confer robustness to embryo
polarization.
INTRODUCTION
InC. elegans embryos, cell fate is established through a series of
asymmetric cell divisions. These divisions rely on reciprocal do-
mains of PAR proteins at the cell cortex. The PAR proteins were
originally found as partitioning-defective mutants in a screen that
directly assayed cell fate in early embryos (Kemphues et al.,
1988). Immediately after fertilization, the C. elegans embryo is
unpolarized, and the anterior PAR protein (aPAR) complex—
consisting of the PDZ domain containing proteins PAR-3 and
PAR-6 and the serine/threonine kinase PKC-3—is distributed
uniformly over the cortex. Cell polarization is initiated about
20 min after fertilization, when a signal from the centrosome trig-
gers local downregulation of the acto-myosin cortex, breaking
cortical symmetry. The break triggers a large-scale movement
of the contractile acto-myosin cortex, which in turn generates
cortical flows that move the aPARs away from the symmetry
breaking site (Goehring et al., 2011; Munro et al., 2004). Removal
of aPARs from this region allows the posterior PAR proteins1380 Cell Reports 8, 1380–1390, September 11, 2014 ª2014 The Au(pPARs)—the RING domain protein PAR-2 and subsequently
the MARK family serine/threonine kinase PAR-1—to localize
to the cortex, forming two antagonistic cortical domains and
defining the anterior-posterior axis. In addition to these essential
par genes, enhancer and suppressor screens identified mole-
cules that contribute to polarization but are only necessary in
a compromised background (Fievet et al., 2013; Labbe´ et al.,
2006; Morton et al., 2012). Further genetic analyses showed
that parallel pathways or backup mechanisms ensure robust-
ness of polarity establishment when the system is perturbed
(Beatty et al., 2010, 2013; Hoege et al., 2010; Motegi et al., 2011).
Robustness in development, or canalization, was defined by
Waddington (1942) as the consistency of a phenotype despite
the genetic diversity that must necessarily exist in a population.
Cell polarization in C. elegans embryos is robust, refractive to
numerous genetic perturbations, and accommodating stochas-
tic variation. For instance, PAR domain size shows little variation
among embryos, even when the general pace of development is
accelerated or slowed down (unpublished data). Upon entry into
mitosis (marked by nuclear envelope breakdown; NEBD) in the
first cell cycle, the aPAR and pPAR cortical domains extend
to 55% and 45% embryo length, respectively. PAR domain
size has a direct effect on cell-fate decisions because the PAR
proteins directly control the distribution of cell-fate determi-
nants. How is PAR domain size precisely controlled in wild-
type embryos?
Despite the robustness of polarization, overexpression or par-
tial depletion of aPARs or pPARs can influence the size of the
cortical PAR domains in otherwise wild-type embryos (Goehring
et al., 2011). Goehring et al. (2011) suggest that the amount
of pPARs limits the size of the posterior domain. Furthermore,
redundancy and feedback loops can buffer polarity against
imbalances in aPAR/pPAR levels (Motegi and Seydoux, 2013).
For example, a weak par-2 mutant is synthetically lethal with
depletion of the tumor suppressor LGL-1 (Beatty et al., 2010;
Hoege et al., 2010). lgl-1() mutants upregulate PAR-6 (Beatty
et al., 2013), suggesting an aPAR/pPAR imbalance. Conversely,
overexpression of LGL-1 can rescue severe loss of PAR-2, indi-
cating that LGL-1 can function for PAR-2 (Beatty et al., 2010;
Hoege et al., 2010). It remains unknown how PAR protein levels
are tightly controlled to achieve the reproducible domain sizes
observed in wild-type embryos. In general, control of protein
homeostasis in one-cell C. elegans embryos is not understood,
despite increasing evidence that protein levels can dictate func-
tion in a dose-dependent manner (Decker et al., 2011; Goehring
and Hyman, 2012; Greenan et al., 2010). Changes in domain sizethors
Figure 1. PAR-5 Levels Correlate with PAR
Domain Size
(A) Time-lapse images of PAR polarity establish-
ment in one-cellC. elegans embryos. Deconvolved
images of control (left) and par-5(RNAi) embryos
(right) expressing GFP::PAR-2 and mCherry::PAR-
6 are shown. Times (min:s) relative to NEBD are
shown. Posterior is to the right. Scale bars, 10 mm.
(B) Control and partial PAR-5-depleted embryos
expressing GFP::PAR-5 and mCherry::PAR-2 at
NEBD. Scale bar, 10 mm.
(C) PAR-2 domain size relative to integrated
GFP::PAR-5 fluorescence intensity in individual
embryos.
See also Figure S1 and Movies S1, S2, S3, and S4.upon increasing or decreasing PAR-2 or PAR-6 levels are more
modest than the changes in total protein would predict (Goehring
et al., 2011). A decrease in PAR-6 by 40% or an increase by 25%
still leads to normal-sized PAR domains (Beatty et al., 2013;
Pacquelet et al., 2008). The amounts of cortical PAR proteins in-
fluence the size of the domains, but this cannot account for the
precise regulation of PAR domain size in the embryo. What other
processes ensure precise and robust polarization?
Here, we find that robust PAR domain size control requires the
ubiquitous PAR protein PAR-5. PAR-5 protein levels correlate
directly with PAR-2 domain size. PAR-5 protein levels appear
to be controlled by a gene regulatory mechanism involving alter-
native 30 UTR splicing of the par-5 mRNA, mediated by the SR
protein kinase SPK-1. par-5mRNA isoform selection was essen-
tial for cell polarity establishment in compromised backgrounds,
including a weak par-2mutant. In addition, par-5mRNA isoform
selection changed in response to perturbations in cell polarity,
suggesting that splicing of par-5 mRNA may react to variability
in the polarization system and thus ensure robustness.
RESULTS
PAR-5 Is a Dose-Dependent Regulator of PAR
Domain Size
To identify molecules regulating PAR domain size, we performed
an RNAi-based loss-of-function screen of 110 genes selectedCell Reports 8, 1380–1390, Sepfor their known involvement in early
embryogenesis (Table S1; So¨nnichsen
et al., 2005). Each gene was tested for
its effect on posterior domain formation
by time-lapse microscopy of embryos ex-
pressing GFP::PAR-2 following depletion
by RNAi. We identified 17 genes leading
to smaller and 5 genes leading to larger
PAR-2 domains. Three genes resulting
in smaller PAR-2 domains act in acto-
myosin contractility and are known to
affect posterior domain size (C56G7.1,
F11H8.4, and F20G4.3; Motegi et al.,
2011; Zonies et al., 2010). One of the can-
didates necessary for normal posterior
domain size was par-5 (M117.2), a geneencoding a 14-3-3 protein already known to be required for cor-
rect cell polarity in earlyC. elegans embryos (Morton et al., 2002).
PAR-5 depletion led to smaller PAR-2 domains of variable size
and a loss of mutual exclusion of aPARs and pPARs (Figure 1A).
par-5(RNAi) embryos often failed to maintain the PAR-2 domain
through mitosis and divided symmetrically. Notably, the charac-
teristic defects changed with the strength of the depletion,
from a specific reduction in the size of the posterior domain
(‘‘mild’’ phenotype) with nonoverlapping cortical PAR domains
to an undetectable posterior domain due to complete overlap
of aPARs and pPARs (‘‘strong’’ phenotype, Figure S1; Movies
S1, S2, S3, and S4). Embryos with a strong loss of PAR-5 pheno-
type also showed contractility defects.
To understand the phenotypic variation in par-5(RNAi) em-
bryos, we assessed whether PAR-2 domain size correlated
with differences in PAR-5 protein levels. We generated a
GFP::PAR-5 transgene under the control of endogenous par-5
regulatory elements (+1 kb promoter and 30 UTR) and inserted
this into a defined ectopic locus (Experimental Procedures).
We used integrated GFP fluorescence intensity to approximate
PAR-5 protein levels at NEBD. GFP::PAR-5 showed uniform
cytoplasmic distribution in early embryos with an enrichment at
the cell cortex (Figure S2B; Morton et al., 2002). Among wild-
type embryos, the SD of GFP::PAR-5 levels was less than 5%
(n = 9), suggesting that PAR-5 may be tightly regulated. PAR-2
domain size exhibited a similarly small amount of variationtember 11, 2014 ª2014 The Authors 1381
(SD 3%; n = 9). Following PAR-5 depletion, we found that the
amount of GFP::PAR-5 correlated linearly with the size of the
PAR-2 domain at NEBD (R2 = 0.80; Figures 1B and 1C). Reduc-
tions in PAR-5 that were at our limit of detection nonetheless had
quantifiable effects on PAR-2 domain size, indicating that
domain size is highly sensitive to PAR-5 levels. These results
indicate that PAR-5 helps set PAR-2 domain size in a dose-
dependent manner. Thus, regulation of PAR-5 levels is critical
to controlling domain size.
par-5 30 UTR Isoform Ratios Are Regulated
How are PAR-5 protein levels precisely regulated? par-5 mRNA
is provided maternally, and thus control over PAR-5 protein
abundance likely occurs posttranscriptionally. PAR-5 protein
levels in the early embryo were similar to those in the gonad
and oocytes based on GFP::PAR-5 fluorescence (Figure S1C),
suggesting that PAR-5 is synthesized in the gonad and contrib-
uted maternally to early embryos. Using 30 rapid amplification of
cDNA ends (RACE) and quantitative PCR (qPCR), we confirmed
earlier findings by Wang and Shakes (1997) that the par-5 locus
makes three mRNA isoforms that share the same coding
sequence but contain alternative 30 UTRs (Figure 2A). In mRNA
isolated from whole worms, the short isoform par-5::utr.3
is most abundant, whereas the long isoforms par-5::utr.1 and
par-5::utr.2 together make up approximately 20% of total par-5
mRNA (Figure 2B).
par-5 mRNA isoform selection seemed constant in worms of
the same stage but varied considerably during development:
total par-5 mRNA abundance decreased during embryogen-
esis, but the relative amounts of par-5::utr.1 and par-5::utr.2
increased significantly, peaking at the first larval stage (Fig-
ure 2B). During postembryonic development, par-5 mRNA
isoform selection shifted progressively toward the short 30
UTR isoform, par-5::utr.3, in line with the general tendency for
C. elegans 30 UTRs (Mangone et al., 2010). This elaborates
the results of Wang and Shakes (1997), indicating that both
par-5 isoform selection and mRNA expression change during
development. In addition, par-5 isoform selection was modu-
lated during the adaptation to growth at higher temperature
(Figure 2C), which correlated with a change in PAR-5 protein
(Figure 2D), whereas overall par-5mRNA levels remained largely
constant (Figure 2C). A progressive increase in PAR-5 protein
levels could also be observed during embryogenesis (Figures
2E and 2F), coincident with an increased contribution of par-
5::utr.2.
par-5::utr.2 results from a splicing event in the 30 UTR, down-
stream of the ‘‘stop’’ codon and thus should be targeted by
nonsense mediated decay (NMD). NMD-deficient worms, how-
ever, showed no differences in par-5mRNA isoform abundance
or changes in PAR-5 protein levels attributable to NMD, suggest-
ing that par-5 isoforms are not degraded by NMD (Figures S3A
and S3B). Instead, par-5 isoform selection appears to be regu-
lated and might be used to control protein levels.
par-5 30 UTR Isoforms Have Different Translational
Efficiencies
30 UTRs regulate protein expression in the C. elegans germline
(Merritt et al., 2008). To determine if par-5’s alternative 30 UTRs1382 Cell Reports 8, 1380–1390, September 11, 2014 ª2014 The Aumight control PAR-5 protein levels, we aimed to assess the
individual contributions of each par-5 mRNA isoform to PAR-5
protein. Because the utr.3 sequence entirely overlaps with
utr.1, and the utr.2 sequence overlaps entirely with utr.1, we
could only design RNAi constructs targeting all three isoforms
or both utr.1 and utr.2. Given these limitations, we could not
assess the contributions of the individual isoforms by selective
depletion.
Instead, we investigated each par-5 isoform for its trans-
lational efficiency. We generated GFP::PAR-5 transgenes
controlled specifically by utr.1, utr.2, or utr.3. As for wild-type
GFP::PAR-5, we used the endogenous promoter region and
inserted a single copy of the transgene into the same ectopic
locus (Figure S3C; Experimental Procedures). To generate the
specific 30 UTRs, we manipulated the splice junctions that are
required to generate par-5::utr.2 and the proximal poly(A) site
required for par-5::utr.3. The splice junctions in the 30 UTR of
par-5 differ from splicing consensus sequences, mainly at the
50 splice site (Figure 3A). We mutated the 50 and 30 splice sites
to perfectly match the consensus sequences (Figure 3B), which
led to the predominant usage of these splice sites and produc-
tion of par-5::utr.2 almost exclusively (Figure 3C), similar to a
construct with prespliced par-5 30 UTR, whose DNA sequence
did not contain the 30 UTR introns. Conversely, we mutated
the splice junctions by flipping the GT and AG dinucleotides
at the 50 and 30 end of the introns, respectively, leading to reten-
tion of these introns and thus the production of only par-5::utr.1
and par-5::utr.3. Additionally, mutating the proximal poly(A)
site led to the exclusive production of the long unspliced
par-5::utr.1. Finally, we removed the distal poly(A) sites to force
production of only the short par-5::utr.3. By changing par-5’s
downstream sequence, we could predictably control par-5
30 UTR selection (Figures 3C, S3D, and S3E; Experimental
Procedures).
To test the three par-5 mRNA isoforms for translational effi-
ciency, we took GFP fluorescence intensity in early embryos
as a measure of PAR-5 expression and standardized this to
the abundance of the respective gfp::par-5::utrmRNA. The three
par-5 isoforms produced different amounts of PAR-5 in one-cell
embryos (Figure 3D), with utr.1 and utr.2 producing themost pro-
tein per mRNA, approximately 3- and 2-fold more than utr.3,
respectively (Figure 3E). We did not observe different localization
or expression patterns of the isoforms (data not shown), arguing
against 30 UTR-dependent spatial or temporal control. Thus, the
long par-5 30 UTRs, utr.1 and utr.2, promote more translation
than the short par-5 30 UTR, utr.3, in early embryos. However,
par-5::utr.1 did not contribute markedly to PAR-5 protein when
other mRNA isoforms could be generated from the same locus
because targeting par-5::utr.1 (and par-5::utr.2) in a strain ex-
pressing GFP::PAR-5 under the control of par-5::utr.1/3 did not
reduce GFP::PAR-5 levels in one-cell embryos (Figure S3E;
Experimental Procedures). par-5::utr.1 mRNA may not be pre-
sent at this particular stage or may contribute negligibly to
PAR-5 protein. Selection between utr.2 and utr.3 therefore
seems decisive in controlling PAR-5 levels. The choice between
utr.2 and utr.3 is mediated by one event: splicing out of the first
30 UTR intron to remove the proximal poly(A) site needed to
generate utr.3.thors
Figure 2. par-5 30 UTR Isoform Selection Is Regulated
(A) Model of par-5 mRNA isoforms.
(B) Cumulative isoform contributions at different developmental stages as determined by qPCR and normalized to ctb-1 and act-1 (green, par-5::utr.1; red,
par-5::utr.2; blue, par-5::utr.3; n = 2–7 biological replicates).
(C) Cumulative isoform contributions during adaptation to growth at 25C as determined by qPCR and normalized to ctb-1 and act-1 (green, par-5::utr.1; red,
par-5::utr.2; blue, par-5::utr.3; n = 3–5 biological replicates).
(D) GFP::PAR-5 levels are increased in embryos grown at 25C. Whiskers indicate 10th–90th percentile ranges. Asterisks indicate statistically significant changes
(two-tailed t test, ***p < 0.001; n = 37 and 17 embryos).
(E) Integrated fluorescence intensity of GFP::PAR-5 at different stages of embryogenesis, normalized to the mean value at time 0 (n = 4–12 embryos). Whiskers
indicate 10th–90th percentile ranges.
(F) Confocal images of an embryo expressing GFP::PAR-5 at different stages of embryogenesis. Times (min) are relative to two-cell stage. Scale bars, 10 mm.SPK-1 Is Required for Efficient par-5 30 UTR Splicing,
Wild-Type PAR-5 Protein Levels, and Correct
Cell Polarity
In order to understand how par-5 isoform selection regulates
PAR-5 protein levels and polarity establishment, we identified
molecules controlling par-5 30 UTR splicing. Alternative splicing
in C. elegans, as in other eukaryotes, is regulated in part by aCell Resemiredundant family of SR proteins and the SR protein kinase
SPK-1 (Kuroyanagi et al., 2000). We tested a subset of these
genes by RNAi for an effect on par-5 isoform selection, selecting
genes required for embryogenesis. From the candidates tested,
only spk-1(RNAi) worms showed a reproducible reduction spe-
cifically in par-5::utr.2, the isoform with the long, spliced 30
UTR (Figures 4A and 4B). spk-1 mRNA levels following partialports 8, 1380–1390, September 11, 2014 ª2014 The Authors 1383
Figure 3. par-5 30 UTR Isoforms Have
Different Translational Efficiencies
(A) Splice site sequences in the par-5 30 UTR. De-
viations from the splicing consensus are indicated
in red.
(B) Strategy for generating par-5 isoform-specific
transgenes.
(C) 30 RACE of ectopic par-5 constructs carrying
mutations in splice and poly(A) sites.
(D) Pseudocolored images of one-cell embryos
(at approximately the same developmental
stage) expressing GFP::PAR-5 under the control
of par-5::utr1, par-5::utr.2, or par-5::utr.3. Purple
indicates low and red high signal intensity. Scale
bars, 10 mm.
(E) Integrated fluorescence intensities of
GFP::PAR-5 under the control of isoform-specific
30 UTRs normalized to GFP::PAR-5 (utr.wt) and
adjusted for abundance of the respective gfp::par-
5::utr mRNA. Whiskers indicate 10th–90th percen-
tile ranges. ANOVA showed significant (p < 0.0001)
differences between the groups. Bonferroni’s
multiple comparison test showed highly significant
(p < 0.001) differences for all combinations (n = 88,
29, and 28 embryos).
See also Figure S3.depletion correlated with the level of par-5::utr.2 in individual bio-
logical replicates (R2 = 0.76; Figure 4C), suggesting a functional
link between SPK-1 and par-5 30 UTR splicing. The same effect
was seen inmRNA isolated from gonads, but not from gonadless
animals (Figure 4D), indicating that SPK-1’s role in par-5::utr.2
splicing is specific to the germline. Thus, the splicing regulator
SPK-1 helps determine par-5 30 UTR selection.
To test if reduced par-5::utr.2 splicing in SPK-1-depleted
worms reflected a global splicing defect, we performed Illumina
sequencing of mRNA from control and spk-1(RNAi) worms and
compared the transcriptomes of the two conditions. Overall,
transcript abundances correlatedwell, so splicing did not appear
to be generally compromised in spk-1(RNAi) worms. To identify
genes that were affected by SPK-1 depletion, we found differ-
ences in exon expression using the DEXSeq package. We also
compared the number of reads spanning a given splice junction.
Combining these 2 strategies and restricting candidates to those
present in all 4 biological replicates yielded a list of 26 genes
whose splicing requires SPK-1 (Figure S4A). This transcrip-
tome-wide approach confirmed the reduction in par-5::utr.2 (Fig-
ures S4B–S4D). As for par-5::utr.2, many of the splicing events
dependent on SPK-1 involved sequences with nonoptimal splice
sites. This was most evident at the 50 splice site, especially at the
fourth and sixth nucleotides downstream of the splice site, which
are preferentially uracils genome wide but were random nucleo-
tides in SPK-1 targets (Figure S4E). Indeed, our splice site-opti-
mized gfp::par-5::utr.2 transgene did not depend on SPK-1 for
splicing (Figure 4E). Thus, SPK-1, at the depletion level used, is
essential for a small number of alternative splicing events,
including splicing of the par-5 30 UTR to generate the translation-
ally active isoform par-5::utr.2.
Our results thus far suggested that SPK-1 controls par-5 30
UTR alternative splicing and thereby isoform selection. Further-
more, par-5 isoform selection may control PAR-5 protein levels1384 Cell Reports 8, 1380–1390, September 11, 2014 ª2014 The Authrough different rates of translation. We therefore wanted to
test the effects of SPK-1 depletion on PAR-5 protein levels.
GFP::PAR-5 levels in spk-1(RNAi) embryos were reproducibly
decreased to approximately 81% of wild-type levels (Figures
4F and 4G). The contribution of SPK-1 was eliminated when
GFP::PAR-5 was controlled by a mutated utr.2 containing
optimal splice sites or by a ‘‘prespliced’’ utr.2 (Figure 4G).
Thus, SPK-1 enhances splicing of the par-5 30 UTR and ensures
wild-type PAR-5 protein levels. We had identified SPK-1 in our
initial screen for PAR-2 domain size defects (Table S1), prompt-
ing us to look again at polarity in spk-1(RNAi) embryos. The
polarity defects of spk-1(RNAi) embryos resembled those of
mild PAR-5 depletion, including slower expansion and smaller
size of the PAR-2 domain (Figures 5A–5C). Therefore, disrupting
par-5 30 UTR selection by interfering with SPK-1-dependent
splicing decreases the fidelity of polarity establishment, similar
to depletion of PAR-5.
par-5 Isoform Selection Contributes to the Robustness
of Cell Polarity
Given that SPK-1 depletion had a very specific effect on par-5
isoform selection, i.e., reduction of par-5::utr.2 by half, we
wanted to determine if depletion of par-5::utr.2 alone would
have a similar effect on PAR-5 abundance and polarity establish-
ment or if par-5::utr.3 alone is sufficient to ensure robust polari-
zation. We found that depletion of par-5::utr.2 reduced PAR-5
by 20%, similar to the 19% reduction we saw in spk-1(RNAi) em-
bryos (Figure 6A). par-5::utr.2(RNAi) embryos, however, showed
a very mild defect in PAR-2 domain size and were viable (Figures
6B and 6C), suggesting that SPK-1 depletion affects additional
processes important for cell polarization.
The more severe polarity defects in spk-1(RNAi) embryos
compared to par-5::utr.2(RNAi) embryos may arise from additive
mis-regulation in SPK-1-depleted embryos. Other SPK-1 targetsthors
Figure 4. Depletion of SPK-1 Affects par-5 30
UTR Splicing and Reduces PAR-5 Protein
Levels
(A) Fold change of par-5::utr.2 in RNAi compared
to control worms. Error bars denote SEM. Aster-
isks indicate statistically significant changes to
control (two-tailed t test, *p < 0.5, ***p < 0.001; nR
2 biological replicates).
(B) par-5mRNA isoform contributions to total par-5
mRNA in control and spk-1(RNAi) worms.
(C) Fold change of par-5::utr.2 in spk-1(RNAi)
worms compared to control worms plotted against
the reduction in spk-1 mRNA in individual RNA
isolations.
(D) Fold change of par-5 isoforms in wild-type
gonads or gonadless worms (pgl-1(bn101)) in spk-
1(RNAi) compared to control. Error bars denote
SEM. Asterisks indicate statistically significant
changes to control (two-tailed t test, ***p < 0.001; n
R 3 biological replicates).
(E) Fold change of par-5::utr.2 made from wild-
type, splice biased, or prespliced 30 UTR in spk-
1(RNAi) compared to control (n R 4 biological
replicates).
(F) Pseudocolored images of one-cell embryos
(at approximately the same developmental stage)
expressing GFP::PAR-5 in control and spk-
1(RNAi). Purple indicates low and red high signal
intensity. Scale bars, 10 mm.
(G) Integrated fluorescence intensity of GFP::PAR-
5 under the control of utr.wt, splice biased utr.2, or
prespliced utr.2 in one-cell spk-1(RNAi) embryos
compared to control. Whiskers indicate 10th–90th
percentile ranges. Error bars denote SEM. Aster-
isks indicate statistically significant changes to
the control condition (two-tailed t test, ***p < 0.001;
n = 326, 103, and 37 embryos).
See also Figure S4.that contribute to the polarity defect in spk-1(RNAi) embryos
might be directly involved in cell polarity or might be factors
that generally compromise development, making the embryos
sensitive to small changes in PAR-5 levels. We attempted to
mimic the spk-1(RNAi) situation by depleting par-5::utr.2 from a
number of viable mutants. We chose mutants in putative targets
of SPK-1 identified by our transcriptome analysis (Figure S4A).
In addition, we tested viable mutants in the polarity pathway.
To assess the specificity of putative synthetic interactions,
we tested mutants in general growth and metabolic pathways,
including mammalian target of rapamycin and insulin signaling
pathways. First, we assessed embryonic viability in mutant
worms depleted of par-5::utr.2 (Figure 6B). The weak par-
2(or640) mutant was highly sensitive to par-5::utr.2 depletion,
with a drop in embryo viability from 90% to 5%. The PAR polarity
mutants pig-1 and ect-2 also showed synthetic interactions with
par-5::utr.2(RNAi). There was little effect of par-5::utr.2 depletion
on mutants in other aspects of cell polarity establishment,Cell Reports 8, 1380–1390, Sepgrowth control, or metabolism. Because
of the strong synthetic interaction
between par-5::utr.2(RNAi) and par-
2(or640), we next tested if cell polaritywas compromised in these embryos by assessing cortical
PAR-2 and PAR-3 domain size in fixed one- and two-cell
embryos (Figure 6C). The par-2(or640) mutant—under control
conditions at the permissive temperature—established and
maintained normal-sized anterior and posterior PAR domains,
despite a 25% reduction in PAR-2 levels (Figure S4H). Depletion
of par-5::utr.2 in par-2(or640) embryos led to a persistent loss
of polarity: PAR-3 occupied the entire cortex in both one- and
two-cell embryos. Reducing PAR-5 protein to a similar extent
by depleting all par-5 mRNA isoforms (par-5mismatch(RNAi);
Figure 6A) did not severely affect embryonic viability (70%
viability compared to 6% in par-5::utr.2(RNAi)) or polarity in the
par-2(or640) background (Figure 6C). The longer, more transla-
tionally active isoform par-5::utr.2 thus appears to be essential
when the pPAR domain is slightly compromised.
Our results suggest that PAR-5 levels determine pPAR domain
size and thus ensure accurate cell polarization. A precisemixture
of par-5 mRNA isoforms with different translational efficienciestember 11, 2014 ª2014 The Authors 1385
Figure 5. spk-1(RNAi) Embryos Exhibit Polarity Defects Reminiscent
of Partial PAR-5 Depletion
(A) Deconvolved images of spk-1(RNAi) embryos expressing GFP::PAR-2 and
mCherry::PAR-6 from time-lapse recordings. Times (min:s) are relative to
NEBD. Posterior is to the right. Scale bar, 10 mm.
(B) PAR-2 domain size in control, spk-1(RNAi), and par-5(RNAi) embryos (n = 6,
12, and 6 embryos).
(C) Accumulation of GFP::PAR-2 at the posterior cortex from symmetry
breaking (12:00) to NEBD (0:00) in control, spk-1(RNAi), and par-5(RNAi)
embryos as determined by the ratio of cortical versus cytoplasmicGFP::PAR-2
fluorescence intensity (n = 8, 7, and 6 embryos).
See also Figure S7.cumulatively provides the correct amount of PAR-5 protein for
the embryo. Given that par-5 30 UTR usage appears regulated
and tightly controlled (Figure 2), we asked if par-5mRNA isoform
ratios adjust according to changing needs for PAR-5. The sensi-
tivity of par-2(or640) embryos to depletion of the efficiently trans-
lated par-5::utr.2 isoform suggested that embryos with defects
in PAR polarity might require more PAR-5. We tested if PAR
polarity defects influence par-5 30 UTR splicing using qPCR to
quantify par-5 isoforms in par-2(or640)mutants. The long, trans-
lationally more active isoforms, par-5::utr.1 and par-5::utr.2,
were higher in par-2(or640) worms compared to control or other
mutant worms grown under the same conditions (Figure 6D).
par-5::utr.2 and par-5::utr.1 produce more protein per mRNA
than the predominant par-5::utr.3 isoform, suggesting that
PAR-5 protein levels could be higher in par-2 mutant embryos
than in wild-type. This prediction could not be tested because
of the different temperature dependencies of the par-2 mutant
and expression of GFP::PAR-5. Our results indicate feedback1386 Cell Reports 8, 1380–1390, September 11, 2014 ª2014 The Aufrom PAR polarity to par-5 isoform selection. The capacity to
change the ratios of par-5 mRNA isoforms may help ensure
polarization when the system is compromised.
DISCUSSION
Here, we found that PAR domain size is regulated by PAR-5,
a known polarity protein. PAR-5 acts in a dose-dependent
way, and as such, PAR-5 levels appear to be tightly controlled
to achieve accurate PAR polarity. The par-5 locus encodes three
mRNAswith different 30 UTRs. The isoforms have different trans-
lational efficiencies. None of the three isoforms alone can sustain
viability because only a construct with a wild-type 30 UTR could
complement a par-5 mutant (it55; data not shown). Only par-
5::utr.2 and par-5::utr.3 contribute measurably to total PAR-5
protein in wild-type embryos. The distinction between utr.2
and utr.3 requires alternative splicing: utr.2 is generated by us-
age of 30 UTR splice sites controlled by the SR protein kinase
SPK-1. SPK-1 helps determine PAR domain size, in part through
its effect on par-5 splicing. Splicing of par-5::utr.2 is essential for
polarity establishment in a weak par-2 mutant, correlating with
an increase in par-5::utr.2 relative to the other par-5 isoforms.
Thus, not only does par-5 isoform selection contribute to the
robustness of polarity establishment by controlling PAR-2
domain size, but PAR polarity feeds back to bias par-5 30 UTR
splicing.
Taking into account the different translational efficiencies of
par-5 mRNA isoforms, the relative contributions of par-5::utr.2
and par-5::utr.3 to total par-5 mRNA reliably predict the
observed PAR-5 protein levels in different conditions (Table 1).
Differences in translational efficiency may be important for pre-
cise regulation on short time scales, such as during develop-
mental decisions. Translation rates, however, may not produce
dramatic effects on steady-state levels if other compensatory
mechanisms, such as control of protein degradation, are active.
Due to its long 30 UTR, par-5::utr.2 provides a larger platform
for integrating signals (RNA binding proteins) and thus can react
to environmental changes or developmental cues. A screen of
posttranscriptional regulators revealed a requirement for MEX-
5 and RNP-4 to maintain wild-type PAR-5 levels (Table S2).
This effect was not isoform specific and hence could not account
for the differences in translational efficiency among par-5mRNA
isoforms.
The selection between par-5 isoforms is controlled largely by
the decision to splice the 30 UTR, a decision regulated by SPK-
1. Qualitative changes controlled by alternative splicing are well
known in developmental decisions (Venables et al., 2012). Here,
we find that alternative 30 UTR splicing does not change the
protein product but rather its abundance in a quantitative way.
Adjustment of par-5 mRNA isoform ratios allows for adjustment
of PAR-5 protein levels according to need. For instance, in a
PAR-2 partial loss-of-function mutant, par-5::utr.2 contributes
more to total par-5 mRNA compared to wild-type worms. PAR
polarity is established normally in this par-2 mutant, but it is
especially sensitive to PAR-5 concentration, suggesting a need
for more PAR-5 protein in this compromised background. We
observed a similar increase in par-5::utr.2 and PAR-5 protein
levels and a dependency on par-5::utr.2 when worms werethors
Figure 6. par-5::utr.2 Is Required for the
Robustness of Cell Polarity
(A) Integratedfluorescence intensity ofGFP::PAR-5
(utr.wt) in one-cell embryos of control, spk-1(RNAi),
par-5::utr.2(RNAi), and par-5mismatch(RNAi)
(dsRNA with reduced complementarity to par-5)
worms. Whiskers indicate 10th–90th percentile
ranges. Asterisks indicate statistically significant
changes to control (two-tailed t test, ***p < 0.001;
n = 276, 476, 84, and 22 embryos).
(B) Effect of par-5::utr.2(RNAi) on embryonic
viability of worm strains carrying nonlethal or
conditional mutations at the permissive tempera-
ture. The ratios of percentages of hatched worms
in par-5::utr.2(RNAi) and control are shown.
(C) Immunofluorescence images from wild-type
and par-2(or640) embryos with or without deple-
tion of par-5::utr.2 or partial par-5 depletion by
par-5mismatch(RNAi). Green indicates PAR-2, red
indicates PAR-3, and blue indicates DNA (DAPI).
Scale bars, 10 mm.
(D) par-5 mRNA isoform contributions to total
par-5 mRNA in N2, par-2(or640), pig-1(gm344),
ect-2(ax751), and spd-5(or213) worms.maintained at 25C for multiple generations (preferred growth
temperature 16C–20C): continuous depletion of par-5::utr.1+2
led to polarity defects, embryonic lethality, and sterility (Figure S5;
data not shown). Both in the par-2 mutant and in worms main-
tained at 25C, the increased dependency on par-5::utr.2 (and
possibly utr.1) could result from (1) more par-5 mRNA depletion
because more of the total par-5 mRNA consists of the long iso-
forms, or (2) requirements for specific isoforms based on their
translational characteristics. For instance, the switch tomore effi-
ciently translated par-5 isoforms could be an adaptation to faster
development at increased temperatures. Their considerably
longer 30 UTRs allow transacting factors to influence the rate of
protein production or concentrate it spatially. In both cases,
adjustments in PAR-5 levels appear to contribute robustness.
PAR-5 protein levels appear to be strictly controlled.
Increased PAR-5 levels are advantageous when polarity estab-
lishment is compromised, but overexpression of PAR-5 is
generally avoided. Introduction of an ectopic copy of par-5 led
to downregulation of the endogenous locus (Figure S6A). The
extent of downregulation was proportional to the amount of pro-
tein made from ectopic par-5 (Figure S6B). Depleting either
endogenous or ectopic par-5 by RNAi led to an upregulation of
expression from the other par-5 locus (Figures S6C and 6D), sug-
gesting compensation to reach normal PAR-5 levels. The extent
of compensation at the mRNA level depended on the transla-
tional efficiency of the par-5 isoform being depleted, indicating
that PAR-5 protein levels rather than mRNAmolecules are moni-
tored. Similar mechanisms might buffer against environmentally
induced fluctuations in gene expression and thus contribute to
the tight control of protein levels.Cell Reports 8, 1380–1390, SepNot all PAR-5-dependent processes
are equally sensitive to levels: in adult
worms, intermediate PAR-5 depletion
interferes with the DNA damage check-point, but only strong PAR-5 depletion disrupts cell-cycle pro-
gression and DNA stability (Aristiza´bal-Corrales et al., 2012).
Nonetheless, tight regulation of protein levels is a general feature
of PAR-5/14-3-3 proteins (Tzivion et al., 2006), and reduction as
well as overexpression can be deleterious. Overexpression of
14-3-3 proteins has been linked to cancer through their role in-
hibiting proapoptotic pathways and controlling the cell cycle
(Martin et al., 2003; Porter et al., 2006; Takihara et al., 2000).
14-3-3 protein levels are elevated in lung cancers (Nakanishi
et al., 1997) and in a high percentage of colorectal carcinoma
samples (Perathoner et al., 2005). Mechanisms to tightly control
PAR-5 levels and prevent overexpression are therefore not only
crucial for cell polarity in C. elegans but appear to be a general
requirement of 14-3-3 proteins.
How does the precise control over PAR-5 levels relate to PAR-
5’s role in polarity? The molecular function of PAR-5 in cell polar-
ity in C. elegans embryos is not known. Work on the Drosophila
homolog of PAR-5, 14-3-3, has shown that phosphorylation
of DmPar3/Bazooka by DmPar1 creates a binding site for
DmPar5/14-3-3 (Benton and St Johnston, 2003). This binding
causes the disassembly of the aPAR complex, which conse-
quently falls off the cortex. The failure of pPARs to exclude
aPARs in C. elegans embryos depleted of PAR-5 and the fact
that we found that PAR-3 interacts with PAR-5 using immu-
noprecipitation followed by mass spectrometry (unpublished
data) suggest a similar function in C. elegans. The phenotype
of par-5(RNAi) embryos, however, is inconsistent with a model
in which PAR-5 only excludes aPARs from the cortex. Our results
showed that par-5(RNAi) and spk-1(RNAi) embryos have
reduced cortical PAR-2 accumulation, and depletion of PAR-5tember 11, 2014 ª2014 The Authors 1387
Table 1. Prediction of PAR-5 Expression Based on 30 UTR Isoform Contributions and Translational Efficiency
Translational Efficiency
Control spk-1(RNAi)
Isoform Abundance Contribution to Protein Isoform Abundance Contribution to Protein
par-5::utr.2 1.75 0.15 0.2625 0.07 0.1225
par-5::utr.3 0.85 0.85 0.7225 0.85 0.7225
Expected PAR-5 protein 0.985 0.845
Measured PAR-5 protein 1 0.812
The contribution of the individual isoforms to total PAR-5 protein was calculated from their translational efficiency relative to GFP::PAR-5 under the
control of par-5::utr.wt and the relative abundance of individual mRNA isoforms. Measured PAR-5 protein levels constitute the mean of integrated
fluorescence intensities in one-cell embryos expressing GFP::PAR-5. par-5::utr.1 did not contribute measurably to PAR-5 levels in early embryos
and thus is excluded from the prediction.in a par-3mutant background led to a par-2-like spindle orienta-
tion defect, together suggesting that PAR-5 has a role in the pos-
terior PAR domain (Figure S7). PAR-5might directly assist PAR-2
loading onto the cortex. Alternatively, PAR-5 might act in a par-
allel polarization pathway, for instance, involving LGL-1. We saw
no synthetic interaction between par-5::utr-2(RNAi) and lgl-1(),
whereas we saw strong synthetic interactions between par-5::
utr-2(RNAi) and a weak par-2 mutant. This difference would be
consistent with a role for PAR-5 in the LGL-1 pathway, which be-
comes essential in the weak par-2mutant, although we have not
investigated this further. In any case, toomuch or too little PAR-5
appears to disrupt the balance between anterior and posterior
domains.
Many aspects of polarity establishment and maintenance in
C. elegans embryos appear to be governed by redundant path-
ways (Motegi and Seydoux, 2013). Backup mechanisms ensure
polarization even in mildly compromised backgrounds. Here, we
have identified a gene regulatory pathway that adds a level of
control over cell polarity: regulation of PAR-5 protein levels
by alternative 30 UTR selection. The capacity to tightly regulate
PAR-5 expression and adjust par-5 isoform selection in
response to polarity defects confers robustness to the polarity
establishment system.
EXPERIMENTAL PROCEDURES
Worm Strains and Maintenance
C. elegans strains were maintained at 16C or 20C (fluorescent lines) on NGM
(nematode growthmedia) with E. coliOP50 as a food source. Transgenic par-5
lines were generated by Mos1-mediated single-copy insertion (Frøkjaer-
Jensen et al., 2008) into ttTi5605 on chromosome II (strains EG4322 and
EG6699). Full-length, single-copy integration was confirmed by PCR. Strain
genotypes can be found in Table S3. Expression of ectopic PAR-5 and
GFP::PAR-5 resembled endogenous par-5 expression because (1) it could
complement the par-5(it55) mutant, (2) isoform selection was comparable to
endogenous par-5 (Figure S3D), and (3) both loci gave rise to similar protein
levels (Figure S6A).
RNAi-Mediated Depletion
Gene knockdown by feeding double-stranded RNA (dsRNA) was performed
essentially as described previously by Kamath et al. (2001) and Timmons
and Fire (1998). L4 worms were transferred to an RNAi plate for variable dura-
tions depending on the experiment, ranging from 6 to 48 hr (Table S4). Worms
on RNAi plates were kept at 25C, except when temperature-sensitive strains
were tested, in which case, strains were kept at 16C. The strength of RNAi
was modulated by adjusting the time the worms were kept on the RNAi plate
or by dilution with bacteria containing the empty L4440 vector. For the control1388 Cell Reports 8, 1380–1390, September 11, 2014 ª2014 The Auconditions, bacteria containing either the empty vector or an mCherry RNAi
feeding construct were used.
Embryonic Lethality Test
Embryonic lethality was scored by transferring at least ten gravid hermaphro-
dites to an NGM-OP50 plate for 1 hr (at 25C) or 2 hr (at 16C), at which time the
mothers were removed and the laid eggs counted. After 2 days and 4 days,
respectively, the number of hatched worms was counted.
RNA Isolation and cDNA Synthesis
A total of 20–100 adult worms (more in the case of early larval stages) or iso-
lated eggs or gonads were collected in 0.1 M NaCl, and mRNA was isolated
using the TRIzol reagent (Life Technologies) according to the manufacturer’s
protocol. cDNA for qPCR experiments was generated using oligo-dT primer
and M-MuLV reverse transcriptase (Thermo Scientific) according to the
manufacturer’s protocol.
30 RACE
For the detection of mRNA isoform 30 ends, reverse transcription was per-
formed using an oligo(dT) primer containing an additional random unique
sequence (‘‘anchor’’: 50-GCATTAAATGCGACTCAGG-30). PCRwas performed
with the anchor primer and a gene-specific primer using High Fidelity PCR
Enzyme Mix (Thermo Scientific) according to the manufacturer’s protocol.
qPCR
For qPCR, one or two primer pairs per transcript were designed to span
(if possible) an exon-exon junction in order to exclude a contribution from
genomic DNA or unspliced pre-mRNA (Table S5). Amplification and detection
wereperformed in triplicateusing iQSYBRGreenSupermix (Bio-Rad) onan iQ5
Real-Time PCR Detection System (Bio-Rad) as a two-step PCR (10 s at 95C
and 30 s at 60C). Nontemplate controls were included, and a melting curve
was generated to confirm the amplification of the expected product. Primers
were tested with serial dilutions of cDNA for efficiency and quantitativeness.
mRNA fold changes between two conditions were calculated using
the -DDCt method (Livak and Schmittgen, 2001). As calibrator gene, ctb-1,
spd-2, or mex-5 was used, depending on the experiment. For the quantifica-
tion of transcript abundance, mRNA levels of the target gene were normalized
to a control gene (ctb-1 or mex-5). For the quantification of contributions of
par-5 mRNA isoforms to total par-5 mRNA, isoform levels for par-5::utr.1
and par-5::utr.2were normalized to total par-5mRNA levels as determined us-
ing primers binding in the common coding sequence. Because par-5::utr.3
does not have any unique sequence or junction, it could not be detected
directly, but its abundance was inferred by subtracting par-5::utr.1 and par-5::
utr.2 from total par-5 mRNA levels.
par-5 mRNA in the gonad makes up most of total par-5 mRNA in the worm
because mRNA isolation from worms lacking a germline (pgl-1(bn101)) only
yielded 20% of par-5 mRNA present in whole wild-type worms. Conversely,
mRNA isolated from gonads was strongly enriched in par-5 mRNA compared
to whole worms. Isoform ratios in whole worms therefore are a good approx-
imation of the situation in the gonad and are not subject to the technical diffi-
culties and consequent variability of mRNA isolation specifically from gonads.thors
mRNA Sequencing
Detailed information on deep sequencing and data analysis can be found in the
Supplemental Experimental Procedures.
Immunofluorescence Protein Localization
Immunofluorescence was performed essentially as described by Oegema
et al. (2001). Samples on poly-L-lysine-coated glass slides were fixed
in 20C methanol for 15 min. Primary (rabbit a-PAR-2 [1:300; gift from Cars-
ten Hoege, MPI-CBG; Hoege et al., 2010] or mouse a-PAR-3 [1:600; Develop-
mental Studies Hybridoma Bank]) and secondary (a-rabbit-Alexa 488 [1:500;
Molecular Probes] or a-mouse-Alexa 564 [1:500; Molecular Probes]) antibody
was added in PBS plus 0.5% Triton X-100 plus 2% BSA, and DNA was visu-
alized using 10 mg/ml DAPI.
Images were acquired on a DeltaVision (Applied Precision) wide-field in-
verted Olympus IX71 microscope equipped with a CCD camera and a Xenon
lamp using a 603 1.4 NA Plan Apochromat objective, controlled by SoftWorx.
Exposure times varied according to staining efficiency and signal intensity
from 50 to 800ms. For each experiment, acquisition conditions were kept con-
stant. The boundary between cortical PAR domains was determined based
on the extent of the PAR-3 domain because the reduction in PAR-2 levels in
par-2(or640) embryos precluded direct measurement of PAR-2 domain size.
Live-Cell Imaging
Embryos for live-cell imaging were prepared as described (Bossinger and
Cowan, 2012). Imaging was usually done on a DeltaVision wide-field inverted
Olympus IX71microscope equippedwith aCCD camera and a Xenon lamp us-
ing a 603 1.4 NA Plan Apochromat objective, controlled by SoftWorx. Usually,
a single midplane image was acquired using the following settings:
d GFP::PAR-2 and GFP::PAR-5: excitation 490/20 nm, emission 528/
38 nm; exposure time: 1 s (PAR-2) or 400 ms (PAR-5); neutral density
filter: 50%, 13 binning; and
d mCherry::PAR-6 and mCherry::PAR-2: excitation 555/28 nm, emission
617/73 nm; exposure time: 1 s; neutral density filter: 50%, 13 binning.
For display, images were deconvolved using SoftWorx.
Although fluorescence intensity measurements were generally done on a
DeltaVision wide-field microscope, results were confirmed on a Zeiss laser-
scanning microscope. Images were taken either on an LSM 510 Zeiss micro-
scope using a 633 1.4 NA Plan Apochromat objective with a diode laser
at 488 nm at 2% laser power, a completely open pinhole, and a pixel size of
0.14 3 0.14 mm, or on an LSM 780 Zeiss microscope using a 633 1.4 NA
Plan Apochromat objective with an argon laser at 488 nm at 1% laser power.
For embryos, five Z slices were acquired with 3 mm spacing.
Image Analysis
GFP::PAR-5 fluorescence intensity was calculated fromDeltaVision or confocal
images by selecting and analyzing a region containing the embryo using
ImageJ. Averagebackground intensitymeasured in a regionoutside the embryo
was subtracted from the average intensity in the embryo region. The integrated
intensity of the embryo was determined by multiplying the size of the region
containing the embryo with its background-subtracted average intensity.
At given time points, measurement of PAR-2 domain size was carried out by
manually measuring the extent of the cortical area enriched in fluorescently
labeled PAR-2 at NEBD relative to the circumference of the embryo (in
ImageJ). For time course analysis, a 20 pixel-wide line along the cortex from
the posterior to the anterior pole was selected, and the maximal fluorescence
intensities along this line for each time point were measured (ImageJ). Domain
sizes were then determined using GNU Octave v.3.2.3 by standardizing em-
bryo length, calculating a running average, subtracting the minimal value,
and identifying the position at which the running average drops below the
half-maximal value. The mean value of multiple embryos was calculated for
each time point, standardized to NEBD.
Cortical accumulation of GFP::PAR-2 from symmetry breaking to NEBD
was determined by calculating—for each time point—the ratio of the mean
of the maximal intensities of three nonoverlapping cortical regions around
the posterior pole to the mean of the average intensities of three nonoverlap-Cell Reping cytoplasmic regions close to the anterior pole (ImageJ). Regions were
approximately 3 mm2.
Contribution of par-5 Isoforms to PAR-5 Protein
Thecontributionof individualmRNA isoforms toPAR-5 protein levelswasdeter-
mined usingGFP::PAR-5 fusion constructs under the control of wild-type or iso-
form-specific par-5 30 UTRs. Production of only the isoform(s) indicated was
confirmed by 30 RACE using a gfp-specific primer. All PCR products were
sequence verified. For an estimation of the relative abundances of isoforms
made from utr.wt, utr.1/2, or utr.1/3, gfp-containing transcripts were preampli-
fied by 30 RACE (15 PCR cycles) and then used for qPCR. In all cases, relative
isoform abundances were comparable to endogenous par-5 (Figure S3D; data
not shown). In addition, the isoform specificity of the transgenes was confirmed
using selective depletion of utr.1- and utr.2-containing transcripts (Figure S3E).
Although par-5::utr.1 is translated when it is the only isoform that can be
made, RNAi using dsRNA targeting par-5::utr.1 and par-5::utr.2 in a strain
expressing GFP::PAR-5 under the control of par-5::utr.1/3 did not reduce
GFP::PAR-5 levels in one-cell embryos, suggesting that par-5::utr.1 does
not contribute to PAR-5 protein in early embryos. This may reflect an absence
of par-5::utr.1mRNA at this developmental stage. In wild-type par-5, the prox-
imal polyadenylation site can be removed by splicing (giving rise to utr.2), but if
splicing does not occur, the proximal poly(A) site is predominantly used (giving
rise to utr.3) and rarely, if ever, skipped to use the distal polyadenylation site
(giving rise to utr.1). The par-5::utr.1 detected by qPCR might constitute a
contribution from tissues other than the gonad. Some par-5::utr.1 might be
present and translated in oocytes and embryos, but this contribution appears
to be below our detection limits.
Visualization and Statistical Analysis
Data analysis was performed in GraphPad Prism v.5.0b and GNU Octave
v.3.2.3. Statistical analysis was done in GraphPad Prism and R v.2.15.1.
GraphPad Prism and GNUPLOT v.4.2/AquaTerm v.1.0.1 were used for data
visualization.
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